Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Special Investigation of COMIRNATY Intramuscular Injection (Investigation of Patients With Underlying Disease Considered to be at High Risk of Aggravation of COVID-19)

NCT04880447 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT04880447
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04880447 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Special Investigation of COMIRNATY Intramuscular Injection (Investigation of Patients With Underlying Disease Considered to be at High Risk of Aggravation of COVID-19)
Lead sponsor
Pfizer
Phase
Observational
Overall status
Completed
Start date
May 26, 2021
Completion date
April 14, 2022
Enrollment
1,075 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19